PDF herunterladen
Synlett 2005(2): 340-342  
DOI: 10.1055/s-2004-837203
LETTER
© Georg Thieme Verlag Stuttgart · New York

Baker’s Yeast-Mediated Regioselective Reduction of 2,4-Dinitroacylanilines: Synthesis of 2-Substituted 6-Nitrobenzimidazoles

Luís F. Olguína, Manuel Jiménez-Estradab, Eduardo Bárzanaa, Arturo Navarro-Ocaña*a
a Depto de Alimentos y Biotecnología, Facultad de Química, ‘E’-UNAM, Cd Universitaria, México, D.F. CP 04510, México
Fax: +52(5622)5309; e-Mail: arturono@servidor.unam.mx;
b Instituto de Química, UNAM, México, D. F, México
Weitere Informationen

Publikationsverlauf

Received 24 September 2004
Publikationsdatum:
17. Dezember 2004 (online)

    Lizenzen und Reprints Alle Artikel dieser Rubrik

Abstract

Several 2,4-dinitro-N-acylanilines were regioselectively reduced at the C-2 position by baker’s yeast in slightly basic media (pH = 7.5) to afford 2-amino-4-nitroacylanilines, which were then cyclized under acidic conditions to the corresponding 2-substituted-6-nitrobenzimidazoles. The benzimidazoles thus obtained can be employed as precursors for bioactive derivatives.

Key words

regioselective - reduction - baker’s yeast - dinitroacyl­anilines - nitrobenzimidazoles

    References

  • 1a D’Arrigo P. Pedrocchi-Fantoni G. Servi S. Adv. Appl. Microbiol.  1997,  44:  81 
    Google Scholar
  • 1b Csuk R. Glänzer BI. Yeast-Mediated Stereoselective Biocatalysis, In Stereoselective Biocatalysis   Patel RN. Marcel-Dekker; New York: 2000.  Chap. 19. p.527 
    Google Scholar
  • 1c Davey CL. Powell LW. Turner NJ. Wells A. In Preparative Biotransformations   Roberts SM. John Wiley and Sons; Chichester: 1994.  Chap. 2. p.8 
    Google Scholar
  • 2 Hudlicky M. In Reductions in Organic Chemistry   American Chemical Society; Washington DC: 1999.  Chap. 8. p.91 
    Google Scholar
  • 3a Navarro-Ocaña A. Jiménez-Estrada M. González-Paredes M. Bárzana E. Synlett  1996,  695 
    CrossrefGoogle Scholar
  • 3b Navarro-Ocaña A. Olguín LF. Luna H. Jiménez-Estrada M. Bárzana E. J. Chem. Soc., Perkin Trans. 1  2001,  2754 
    CrossrefGoogle Scholar
  • 4 Kapinos L. Sigel H. Eur. J. Inorg. Chem.  1999,  1781 
    CrossrefGoogle Scholar
  • 5 Sarlauskas J. Dickancaite E. Nemeikaite A. Anusevicius Z. Nivinskas Segura-Aguilar HJ. Cenas N. Arch. Biochim. Biophys.  1997,  346:  219 
    CrossrefGoogle Scholar
  • 6 Zou R. Ayres KR. Drach JC. Townsend LB. J. Med. Chem.  1996,  39:  3477 
    CrossrefPubMedGoogle Scholar
  • 7 Purygin PP. Sergeeva LI. KuzŽmina VE. Labazova ON. Pharm. Chem. J.  2002,  36 (8):  415. 
    CrossrefGoogle Scholar
  • 8 Njoya Y. Boufatah N. Gellis A. Rathelot P. Crozet PM. Vanelle P. Heterocycles  2002,  57 (8):  1423 
    CrossrefGoogle Scholar
  • 9 Dincer S. Dyes Pigm.  2002,  53:  263 
    CrossrefGoogle Scholar
  • 10 Rodembusch FS. Buckup T. Segala M. Tavares L. Bordalo-Correia RR. Stefani V. Chem. Phys.  2004,  305:  115 
    CrossrefGoogle Scholar
  • 11a Brain CT. Steer JT. J. Org. Chem.  2003,  68:  6814 
    CrossrefGoogle Scholar
  • 11b Brain CT. Brunton SA. Tetrahedron Lett.  2002,  43:  1893 
    CrossrefGoogle Scholar
  • 12 Esser F. Ehrengart P. Ignatow HP. J. Chem. Soc., Perkin Trans. 1  1999,  1153 
    CrossrefGoogle Scholar
  • 13a Kihel AE. Benchidmi M. Essassi EM. Danion-Bougot R. Synth. Commun.  1999,  29:  387 
    Google Scholar
  • 13b Chauhan PMS. Bhakuni DS. Indian. J. Chem., Sect. B  1986,  25:  1146 
    Google Scholar
  • 14a Thomas JB. Fall MJ. Cooper JB. Burgess JP. Carroll FI. Tetrahedron Lett.  1997,  29:  5099 
    CrossrefGoogle Scholar
  • 14b Patel KM. Patel VH. Patel MP. Patel RG. Dyes Pigm.  2002,  55:  53 
    CrossrefGoogle Scholar
  • 14c

    See ref.5 and ref.10

    Crossref
  • 15a Porter HK. Org. React.  1973,  20:  455 
    CrossrefGoogle Scholar
  • 15b Terpko MO. Heck RF. J. Org. Chem.  1980,  45:  4992 
    CrossrefGoogle Scholar
  • 16 Phillips MA. J. Chem. Soc.  1928,  2393 
    CrossrefGoogle Scholar
  • 17 Vogel’s Textbook of Practical Organic Chemistry   5th ed.:  Furniss BS. Hannaford AJ. Smith PWG. Tatchell AR. Longman; London: 1989. 
    Google Scholar
  • 19 Ries WJ. Mihm G. Narr B. Hasselbach KM. Wittneben H. Entzeroth M. van Meel JCA. Wienen W. Hauel NH. J. Med. Chem.  1993,  36:  4040 
    CrossrefPubMedGoogle Scholar
18

Representative Reduction of Substituted 2,4-Dinitro- N -acylanilines with Baker’s Yeast.
In a typical experiment, the substrate 2,4-dinitroacylaniline 1e (0.5 mmol) was dissolved in 5 mL of acetone-EtOH 1:1 v/v and the resulting solution was added to a prehydrated (30 min) suspension of 10 g dried yeast (Saf-instant) in 100 mL of 0.5 M phosphate buffer (pH = 7.5) and containing 10 g of sucrose at 30 °C. The mixture was stirred on an orbital shaker (150 rpm) and the pH was kept constant by adding portions of 0.5 M NaOH. The stirring was continued until all the substrate was consumed or remained unchanged as judged by TLC. The mixture was then saturated with NaCl, diluted with 100 mL of EtOAc and combined with 20 g of celite. After vigorous stirring, the cells were removed by vacuum filtration over a bed of celite, the two phases of the filtrate were separated and the aqueous layer extracted with EtOAc (3 × 100 mL); the filter cake was rinsed with EtOAc (3 × 100 mL) and the combined organic extracts were dried over anhyd Na2SO4 and concentrated in vacuo. The resulting oil was purified by column chromatography on silica gel. Elution with CH2Cl2-MeOH (95:5) yielded 2-amino-4-nitroacylaniline 2e:
1H NMR (300 MHz, CDCl3-d 6-DMSO): δ = 9.14 (1 H, s, NH), 7.73 (1 H, d, J = 9.0 Hz, ArH6), 7.65 (1 H, d, J = 2.7 Hz, ArH3), 7.47 (1 H, dd, J 5-6 = 8.8 Hz, J 5-3 = 2.8 Hz, ArH5), 5.05 (2 H, s, NH2), 2.44 (2 H, t, CH2, C-1), 2.44 (2 H, sext, CH2, C-3), 1.69 (2 H, q, CH2, C-2), 0.95 (2 H, t, CH3, C-4). 13C NMR (75 MHz, CDCl3-d 6-DMSO): δ = 172.00, 144.17, 140.11, 129.78, 123.03, 111.83, 110.171, 35.92, 27.14, 21.75, 13.33. IR (KBr): νmax = 3452 (Ar-NH2), 3374, 3255
(-NH), 2916, 2847 (CH2, CH3), 1653 (C=O), 1347
(Ar-NO2), 876, 739 (NH2, Ar) cm-1. MS (EI): m/z (%) = 237 (40) [M+], 180 (12), 177 (29), 153 (100), 107 (12), 85 (25), 57 (35). Yield: 214 mg (90%); mp 123-125 °C.
A typical example for the cyclization of 2-amino-4-nitro-acylanilines into substituted nitrobenzimidazoles is as follows: 2,4-dinitroacylaniline 2e (118.5 mg, 0.5 mmol) was dissolved in 5 mL of glacial acetic acid and then this solution was carried out at 60 °C for 6 h. After completion, the solution was concentrated in a rotary evaporator to remove the HOAc and the residue was recrystallized from MeOH-H2O to afford 2-butyl-6-nitrobenzimidazole (3e):
1H NMR (300 MHz, CDCl3-d 6-DMSO): δ = 12.14 (1 H, s, NH1), 8.50 (1 H, d, J 7-5 = 2.0 Hz, ArH7), 8.19 (1 H, dd, J 5-4 = 8.8 Hz, J 5-7 = 2.0 Hz, ArH5), 7.60 (1 H, d, J 4-5 = 8.8 Hz, ArH4), 3.00 (2 H, t, CH2, C-1), 1.89 (2 H, q, CH2, C-2), 1.46 (2 H, sext, CH2, C-3), 0.96 (3 H, t, CH3, C-4). 13C NMR (75 MHz, CDCl3-d 6-DMSO): δ = 159.59, 142.50. 114.44, 118.48, 143.57, 111.56, 138.41, 29.95, 29.21, 22.42, 13.69. IR (KBr): ν = 3430 (NH), 3000-2800 (NH), 2980, 2939 (CH2, CH3), 1625 (Ar), 1592, 1472, 1452 and 1418 (C=N and C=C), 1514 and 1341 (Ar-NO2), 825, 734 (Ar) cm-1. MS (EI): m/z (%) = 219 (6) [M+], 218 (1), 204 (5), 190 (24), 177 (100), 158 (7), 144 (12), 131 (32). Yield: 98.5 mg (90%); mp 134-135 °C (Lit.19 139-141 °C).